RegeneRx Biopharmaceuticals, Inc.
RGRX · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $291 | $1,232 | $428 | $640 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $16 | $20 | $50 | $42 |
| Total Curr. Assets | $307 | $1,252 | $478 | $682 |
| Property Plant & Equip (Net) | $70 | $28 | $68 | $24 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $6 | $6 | $6 | $6 |
| Total NC Assets | $75 | $33 | $74 | $30 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $382 | $1,285 | $552 | $712 |
| Liabilities | – | – | – | – |
| Payables | $64 | $64 | $39 | $44 |
| Short-Term Debt | $87 | $56 | $75 | $54 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $77 | $77 | $77 | $77 |
| Other Curr. Liab. | $326 | $234 | $209 | $68 |
| Total Curr. Liab. | $554 | $430 | $400 | $242 |
| LT Debt | $1,403 | $1,137 | $952 | $708 |
| Deferred Rev, NC | $1,871 | $1,948 | $2,025 | $2,101 |
| Deferred Tax Liab, NC | -$1,373 | -$1,137 | $0 | -$708 |
| Other NC Liab. | $1,871 | $1,948 | $0 | $0 |
| Total NC Liab. | $3,274 | $3,085 | $2,976 | $2,809 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $74 | $28 | $69 | $27 |
| Total Liabilities | $3,828 | $3,515 | $3,376 | $3,052 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $144 | $144 | $133 | $132 |
| Retained Earnings | -$112,217 | -$110,490 | -$108,892 | -$107,369 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $108,628 | $108,116 | $105,935 | $104,897 |
| Total Equity | -$3,445 | -$2,230 | -$2,824 | -$2,340 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $382 | $1,285 | $552 | $712 |
| Net Debt | $1,199 | -$39 | $598 | $122 |